Last reviewed · How we verify

NCT04364087

Glucose Metabolism and Live Birth Outcomes in PCOS

Completed Last updated 24 August 2025
What this trial tests

trial testing Oral glucose tolerance test in PCOS in 1,208 participants. Completed in 31 August 2022.

Timeline
1 June 2020
Primary endpoint
31 August 2022
31 August 2022

Quick facts

Lead sponsorMỹ Đức Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,208
Start date1 June 2020
Primary completion31 August 2022
Estimated completion31 August 2022
Sites1 location across Vietnam

Drugs / interventions tested

Conditions studied

Sponsor

Mỹ Đức Hospital

Who can join

Adults 18 to 40, female only, with PCOS or Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Polycystic ovary syndrome (PCOS) is a common endocrine and reproductive disorder in which insulin resistance (IR) is proposed as a key pathophysiological feature of the disease's symptoms and consequences. Diabetes and rediabetes, a significant consequence of IR, are related to a higher risk of diabetes mellitus, future cardiovascular events, and adverse pregnancy outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of glucose metabolism abnormalities on live birth rate in South-East Asian women with polycystic ovary syndrome.
    Nguyen NT, Ho VNA, Pham TD, Nguyen MHN, et al · · 2026 · PMID 41836352 · DOI 10.1093/hropen/hoag012

Verify or expand the search:

Other trials of Oral glucose tolerance test

Trials testing the same drug.

Other recruiting trials for PCOS

Currently open trials in the same condition.

Other Mỹ Đức Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04364087.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing